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Background: The purpose of this study was to evaluate by histopathological analysis
and Energy Dispersive X-ray analysis (EDAX), the ability to occlude cerebral an-
eurysms by the multilayer ﬂow modulator cranial device.
Methods: The devices were implanted in the subclavian artery of six rabbit models,
following induction of an aneurysm in the right carotid artery, collateral to the
implanted segment of the subclavian and in the aorta. Device implantation was per-
formed 4 weeks after aneurysm creation, and implanted for a duration of 4 weeks. The
aim of the study was to demonstrate biocompatibility of the device as well as device
integration without complication.
Results: Gross examination and histopathological analysis showed the aneurysmal
areas of all six specimens were obturated with an old mixed thrombus, showing the
lines of Zahn (Figure 1). The devices were also markedly integrated into the arterial
wall with no evidence of local intolerance, and no aneurysm rupture or leakage was
observed with the 2 specimens. EDAX analysis of the specimens revealed that in all
areas investigated in the tissues surrounding the device struts, there was an absence of
nickel and titanium. No signiﬁcant intra-arterial inﬂammatory reaction was recorded
across all of the implanted arteries. There was also no metal release into the sur-
rounding tissues.Conclusions: The intracranial multilayer ﬂow modulator device therefore offers a
biocompatibly viable intra-arterial stent alternative. Further studies to assess its
biocompatibility, safety and effectiveness are needed, including in vitro studies and
long-term clinical trials.
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Background: The CeloNova COBRA PzF Coronary Stent is a new stent design,
balloon expandable cobalt chromium alloy coronary stent that is pre-mounted on a
custom rapid exchange balloon delivery catheter. The alloy stent is surface treated
with a nano-layer Polyzene-F (PzF). Polyzene-F is an inorganic polymer with a high
molecular weight. In vitro studies have indicated that the nano-layer surface treatment
is a nonthrombogenic and has anti-inﬂammatory properties.
Methods: A control COBRA BMS stent was specially manufactured for this exper-
iment, designed as the same stent without the PzF coating. Following stent implan-
tation, 32 external right iliac rabbit arteries were harvested at 7 days for electron
microscopy analysis, half cylinder for thrombus area formation and the other half
cylinder for reendothelialization. Five animals were examined at day 3 and 5 animals
at day 5. Each animal received in one leg a COBRA PzF stent and on the opposite leg
a control stent randomly assigned. The 2 half cylinders were examined for
reendothelialization.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/NeResults: The 3 occluded stents were observed in control COBRA BMS group
(3/27, 11.11%) versus 0 (0/25, 0%) in the COBRA PzF group (p ¼ 0.04). At
day 7, almost a complete coverage of endothelial cells was observed in both
group. 99.86 +/- 0.09 % in the COBRA BMS group versus 99.54 +/- 0.25% in
the COBRA PzF group, (p ¼ NS). No thrombus area was observed in both
group at day 7, 0% versus 0%, (p ¼ NS). At day 3, more than half area of the
examined pieces was reendotheliazed in both group, 54.25 +/- 4.4 % in the
COBRA PzF group versus 53.78 +/- 4.4 % in the COBRA BMS group (p ¼
NS), and reached 78.30 +/- 3.7 % in the COBRA PzF group versus 79.03 +/-
4.% in the COBRA BMS group (p ¼ NS). All stents were well expanded
against the arterial wall and no struts were malapposed with no difference
between groups.
Conclusions: There is a signiﬁcant reduction of stent occlusion in the COBRA PzF
group as compared to the same stent without PzF modiﬁed surface with a complete
and rapid reendothelialization in both group at day 7 that compare favorably with
previous data. These data will serve as impetus to perform clinical study with
reduction of dual antiplatelet therapy.
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Background: Functional tricuspid regurgitation (FTR) is the most frequent eti-
ology of tricuspid pathology, and interest has been rising recently in the phys-
iopathology and transcatheter treatment of FTR. The aim of the study is to
develop a computational model for the analysis of the tricuspid valve (TV) from
in vivo data.
Methods: Full volume 3D echo datasets were obtained from 10 patients with mitral
regurgitation (MR) without FTR and compared with those from 10 patients with MR
and associated moderate-to-severe FTR. Finite element models were derived for a
normal TV and for a dilated TV with FTR; TV geometries were characterized by
annular dimension of anterior leaﬂet (AL), posterior leaﬂet (PL), septal leaﬂet (SL),
inter-commissural distances (IC), annular circumference (AC), 2D and 3D area as
measured through 3D echo imaging. Stress distribution, papillary muscle forces and
chordal tensions were compared.
Results: Annular dilation was associated with increased AL (p¼0.0064) and PL
(p¼0.0078), as well as anteroposterior IC and the anteroseptal IC (p< 0.05). AC,
2D area and 3D area were signiﬁcant greater in the dilated TV (p< 0.05). Stress
distribution, papillary muscle forces and chordal tensions analysis conﬁrmed the
biomechanical alterations related to annular dilation; the dilated TV model showed
higher stresses (+30%) and papillary muscles forces (+80%) due to lack of
coaptation.Conclusions: Computational models of FTR can provide further insight into the
physiopathology of TV. This approach could be useful to design new transcatheter
devices, and to validate new procedures for the treatment of FTR.w Devices and Innovation B131
